Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. (October 2021)
- Record Type:
- Journal Article
- Title:
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. (October 2021)
- Main Title:
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
- Authors:
- Hausmann, Jonathan S
Kennedy, Kevin
Simard, Julia F
Liew, Jean W
Sparks, Jeffrey A
Moni, Tarin T
Harrison, Carly
Larché, Maggie J
Levine, Mitchell
Sattui, Sebastian E
Semalulu, Teresa
Foster, Gary
Surangiwala, Salman
Thabane, Lehana
Beesley, Richard P
Durrant, Karen L
Mateus, Elsa F
Mingolla, Serena
Nudel, Michal
Palmerlee, Candace A
Richards, Dawn P
Liew, David F L
Hill, Catherine L
Bhana, Suleman
Costello, Wendy
Grainger, Rebecca
Machado, Pedro M
Robinson, Philip C
Sufka, Paul
Wallace, Zachary S
Yazdany, Jinoos
Sirotich, Emily
Robinson, Philip C.
Bhana, Suleman
Liew, Jean W.
Sufka, Paul H.
Singh, Namrata
Howard, Richard A.
Kim, Alfred H.J.
Westrich-Robertson, Tiffany
Sirotich, Emily
Tsui, Edmund
Duarte-Garcia, Ali
Sparks, Jeffrey A.
Tam, Herman
Jayatilleke, Arundathi
Konig, Maximilian F.
Graef, Elizabeth R.
Putman, Michael S.
Syed, Reema H.
Korsten, Peter
Mateus, Elsa
Sattui, Sebastian E.
Wallace, Zachary S.
Laura, Upton A.
Adam, Kilian
Chock, Yu Pei Eugenia
White, Douglas W.
Zamora, Geraldine T.
Traboco, Lisa S.
Patel, Aarat M.
Grainger, Rebecca
Ugarte-Gil, Manuel F.
Gianfrancesco, Milena A.
Amigues, Isabelle
Sanchez-Alvarez, Catalina
Trupin, Laura
Jacobsohn, Lindsay R.
Beesley, Richard P.
Hoyer, Bimba F.
Machado, Pedro M.
Makan, Kavita
Gossec, Laure
Priyank, Chaudhary
Leipe, Jan
Wallace, Beth
Angeles-Han, Sheila T.
Almaghlouth, Ibrahim A.
Katherine, Wysham D.
Padula, Anthony S.
Berenbaum, Francis
Treemarcki, Erin M.
Sinha, Rashmi
Lewandowski, Laura B.
Webb, Kate
Young, Kristen J.
Bulina, Inita
Herrera Uribe, Sebastian
Rubinstein, Tamar B.
Nolan, Marc W.
Ang, Elizabeth Y.
Venuturupalli, Swamy R.
Hausmann, Jonathan S.
Dubreuil, Maureen
Pisoni, Cecilia N.
Cosatti, Micaela A.
Campos, Jose
Simard, Julia F.
Conway, Richard
Peterson, Tiffany M.
Harrison, Carly O.
Felix, Christele
Richards, Dawn P.
Proulx, Laurie
Akpabio, Akpabio A.
Worthing, Angus B.
Laidlaw, Lynn R.
Reid, Pankti
Palmerlee, Candace A.
Danila, Maria I.
Sahar, Lotfi-Emran
Linh, Ngo Q.
Agarwal, Arnav
Studenic, Paul
Liew, David F.L.
Larche, Maggie J.
Mingolla, Serena A.M.
Zamora, Erick A.
Angevare, Saskya S.
Sinha, Rashmi R.
Durrant, Karen L.W.
Peirce, Andrea
Somers, Emily C.
Cappelli, Laura C.
Frankel, Brittany A.
Kumar, Bharat
Silinsky Krupnikova, Sonia D.
Rosario Vega, Jorge A.
Frankovich, Jourdan
Fernandez-Ruiz, Ruth
Posada Velásquez, Marcela
Yeoh, Su-Ann
Marino, Maria
Nudel, Michal
Scott, Chrisiaan
Rodríguez, Cecilia
Martín Mancheño, Ana I.
Seo, Philip
Gamboa-Cárdenas, Rocío V.
Pimentel-Quiroz, Victor R.
Reátegui-Sokolova, Cristina
Kihara, Mari
Lin, Chung M.A.
Kattula, Dheera
Laila, Girgis
Carmona, Loreto
Wallace, John
Yazdany, Jinoos
Costello, Wendy
Gore-massy, Monique C.
Tomasella, Laura-Ann
Kodek, Moré A.
… (more) - Abstract:
- Summary: Background: The impact and consequences of the COVID-19 pandemic on people with rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance Patient Experience Survey to assess the effects of the COVID-19 pandemic on people with rheumatic disease worldwide. Methods: Survey questions were developed by key stakeholder groups and disseminated worldwide through social media, websites, and patient support organisations. Questions included demographics, rheumatic disease diagnosis, COVID-19 diagnosis, adoption of protective behaviours to mitigate COVID-19 exposure, medication access and changes, health-care access and communication with rheumatologists, and changes in employment or schooling. Adults age 18 years and older with inflammatory or autoimmune rheumatic diseases were eligible for inclusion. We included participants with and without a COVID-19 diagnosis. We excluded participants reporting only non-inflammatory rheumatic diseases such as fibromyalgia or osteoarthritis. Findings: 12 117 responses to the survey were received between April 3 and May 8, 2020, and of these, 10 407 respondents had included appropriate age data. We included complete responses from 9300 adults with rheumatic disease (mean age 46·1 years; 8375 [90·1%] women, 893 [9·6%] men, and 32 [0·3%] participants who identified as non-binary). 6273 (67·5%) of respondents identified as White, 1565 (16·8%) as Latin American, 198 (2·1%) as Black, 190 (2·0%) as Asian, and 42 (0·5%)Summary: Background: The impact and consequences of the COVID-19 pandemic on people with rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance Patient Experience Survey to assess the effects of the COVID-19 pandemic on people with rheumatic disease worldwide. Methods: Survey questions were developed by key stakeholder groups and disseminated worldwide through social media, websites, and patient support organisations. Questions included demographics, rheumatic disease diagnosis, COVID-19 diagnosis, adoption of protective behaviours to mitigate COVID-19 exposure, medication access and changes, health-care access and communication with rheumatologists, and changes in employment or schooling. Adults age 18 years and older with inflammatory or autoimmune rheumatic diseases were eligible for inclusion. We included participants with and without a COVID-19 diagnosis. We excluded participants reporting only non-inflammatory rheumatic diseases such as fibromyalgia or osteoarthritis. Findings: 12 117 responses to the survey were received between April 3 and May 8, 2020, and of these, 10 407 respondents had included appropriate age data. We included complete responses from 9300 adults with rheumatic disease (mean age 46·1 years; 8375 [90·1%] women, 893 [9·6%] men, and 32 [0·3%] participants who identified as non-binary). 6273 (67·5%) of respondents identified as White, 1565 (16·8%) as Latin American, 198 (2·1%) as Black, 190 (2·0%) as Asian, and 42 (0·5%) as Native American or Aboriginal or First Nation. The most common rheumatic disease diagnoses included rheumatoid arthritis (3636 [39·1%] of 9300), systemic lupus erythematosus (2882 [31·0%]), and Sjögren's syndrome (1290 [13·9%]). Most respondents (6921 [82·0%] of 8441) continued their antirheumatic medications as prescribed. Almost all (9266 [99·7%] of 9297) respondents adopted protective behaviours to limit SARS-CoV-2 exposure. A change in employment status occurred in 2524 (27·1%) of 9300) of respondents, with a 13·6% decrease in the number in full-time employment (from 4066 to 3514). Interpretation: People with rheumatic disease maintained therapy and followed public health advice to mitigate the risks of COVID-19. Substantial employment status changes occurred, with potential implications for health-care access, medication affordability, mental health, and rheumatic disease activity. Funding: American College of Rheumatology. … (more)
- Is Part Of:
- Lancet. Volume 3:Number 10(2021)
- Journal:
- Lancet
- Issue:
- Volume 3:Number 10(2021)
- Issue Display:
- Volume 3, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 3
- Issue:
- 10
- Issue Sort Value:
- 2021-0003-0010-0000
- Page Start:
- e707
- Page End:
- e714
- Publication Date:
- 2021-10
- Subjects:
- Rheumatology -- periodicals
616.72305 - Journal URLs:
- https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/S2665-9913(21)00175-2 ↗
- Languages:
- English
- ISSNs:
- 2665-9913
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19564.xml